Iron metabolism in hemodialyzed patients – a story half told?
暂无分享,去创建一个
I. Slotki | J. Małyszko | J. Matuszkiewicz-Rowińska | J. Małyszko | E. Koc-Żórawska | N. Levin-Iaina | I. Głowińska
[1] D. Charytan,et al. Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] M. Banach,et al. Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease , 2013, Archives of medical science : AMS.
[3] Hsuan-Liang Liu,et al. Serum p-cresyl sulfate predicts cardiovascular disease and mortality in elderly hemodialysis patients , 2013, Archives of medical science : AMS.
[4] Teresa Oliveira,et al. Biochemistry of adipose tissue: an endocrine organ , 2013, Archives of medical science : AMS.
[5] Z. Cabantchik,et al. Non‐transferrin bound iron in Thalassemia: Differential detection of redox active forms in children and older patients , 2012, American journal of hematology.
[6] W. Aronow. Editorial on management of diabetes mellitus with coronary artery disease , 2011, Archives of medical science : AMS.
[7] D. Mikhailidis,et al. IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis , 2011, Archives of medical science : AMS.
[8] J. Małyszko,et al. Lack of non-transferrin-bound iron in heart transplant recipients. , 2011, Transplantation proceedings.
[9] M. Myśliwiec,et al. Iron metabolism in kidney allograft recipients: still a mystery? , 2011, Transplantation proceedings.
[10] André M. N. Silva,et al. Influence of non-enzymatic post-translation modifications on the ability of human serum albumin to bind iron. Implications for non-transferrin-bound iron speciation. , 2009, Biochimica et biophysica acta.
[11] J. Małyszko,et al. Serum Prohepcidin and Hepcidin in Hemodialyzed Patients Undergoing Iron Therapy , 2009, Kidney and Blood Pressure Research.
[12] Grace H. Lee,et al. Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] R. Fischer,et al. Non-transferrin-bound iron in plasma following administration of oral iron drugs , 2008, BioMetals.
[14] J. Gollan,et al. Iron‐mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol , 2007, Hepatology.
[15] R. Prabhu,et al. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[16] T. Ganz,et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. , 2005, Blood.
[17] Z. Cabantchik,et al. LPI-labile plasma iron in iron overload. , 2005, Best practice & research. Clinical haematology.
[18] B. Grandchamp,et al. Effects of Intravenous Polymaltose Iron on Oxidant Stress and Non-Transferrin-Bound Iron in Hemodialysis Patients , 2005, Nephron Clinical Practice.
[19] M. Burritt,et al. Liver Hepcidin mRNA Correlates With Iron Stores, but Not Inflammation, in Patients With Chronic Hepatitis C , 2005, Journal of clinical gastroenterology.
[20] A. Levy,et al. Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes. , 2004, Diabetes care.
[21] B. Scheiber-Mojdehkar,et al. Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation. , 2004, Journal of the American Society of Nephrology : JASN.
[22] B. Scheiber-Mojdehkar,et al. Transient increase of the labile iron pool in HepG2 cells by intravenous iron preparations. , 2003, European journal of biochemistry.
[23] I. Slotki,et al. Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin‐bound iron in dialysis patients , 2002, European journal of clinical investigation.
[24] S. Kersting,et al. Nontransferrin‐bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion , 2002, European journal of clinical investigation.
[25] M. Cappellini,et al. Non-transferrin-bound iron in alcohol abusers. , 2001, Alcoholism, clinical and experimental research.
[26] W. Breuer,et al. The importance of non-transferrin bound iron in disorders of iron metabolism. , 2000, Transfusion science.
[27] E. Morgan,et al. Characterisation of non-transferrin-bound iron (ferric citrate) uptake by rat hepatocytes in culture. , 1998, Biochimica et biophysica acta.
[28] D. Meyers. The iron hypothesis—Does iron cause atherosclerosis? , 1996, Clinical cardiology.
[29] D. Rao,et al. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. , 1993, The New England journal of medicine.
[30] Heikki Korpela,et al. High Stored Iron Levels Are Associated With Excess Risk of Myocardial Infarction in Eastern Finnish Men , 1992, Circulation.
[31] C. Hershko,et al. NON‐TRANSFERRIN PLASMA IRON , 1987, British journal of haematology.
[32] C. Craven,et al. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[33] P. Brissot,et al. Characterization of non-transferrin-bound iron clearance by rat liver. , 1986, The Journal of biological chemistry.
[34] Winfred C. Wang,et al. Non-transferrin-bound iron in long-term transfusion in children with congenital anemias. , 1986, The Journal of pediatrics.
[35] P. Brissot,et al. Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states. , 1985, The Journal of clinical investigation.
[36] B. Halliwell,et al. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. , 1985, Clinical science.
[37] M. Durlik,et al. Iron metabolism in solid‑organ transplantation: how far are we from solving the mystery? , 2012, Polskie Archiwum Medycyny Wewnetrznej.
[38] D. Brancaccio,et al. Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach. , 2004, Journal of the American Society of Nephrology : JASN.